Brenda S. Furlow - 07 Dec 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
SVP - GENERAL COUNSEL
Signature
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
07 Dec 2022
Net transactions value
-$419,500
Form type
4
Filing time
09 Dec 2022, 15:48:08 UTC
Previous filing
17 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $25,010 +800 +3.1% $31.26 26,892 07 Dec 2022 Direct
transaction TECH Common Stock Sale $65,605 -800 -3% $82.01 26,092 07 Dec 2022 Direct
transaction TECH Common Stock Options Exercise $232,906 +7,450 +29% $31.26 33,542 08 Dec 2022 Direct
transaction TECH Common Stock Sale $611,810 -7,450 -22% $82.12 26,092 08 Dec 2022 Direct F1
holding TECH Common Stock 5,320 07 Dec 2022 By Trust #1
holding TECH Common Stock 5,320 07 Dec 2022 By Trust #2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -800 -2.1% $0.000000 37,212 07 Dec 2022 Common Stock 800 $31.26 Direct F2
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -7,450 -20% $0.000000 29,762 08 Dec 2022 Common Stock 7,450 $31.26 Direct F2
holding TECH Stock Options (Right to Buy) 66,248 07 Dec 2022 Common Stock 66,248 $44.33 Direct F2
holding TECH Stock Options (Right to Buy) 39,872 07 Dec 2022 Common Stock 39,872 $47.60 Direct F2
holding TECH Stock Options (Right to Buy) 53,160 07 Dec 2022 Common Stock 53,160 $47.60 Direct F3
holding TECH Restricted Stock Units 6,716 07 Dec 2022 Common Stock 6,716 Direct F4, F5
holding TECH Stock Options (Right to Buy) 29,968 07 Dec 2022 Common Stock 29,968 $66.97 Direct F5
holding TECH Stock Options (Right to Buy) 39,960 07 Dec 2022 Common Stock 39,960 $66.97 Direct F6
holding TECH Stock Options (Right to Buy) $33,300 07 Dec 2022 Common Stock $33,300 $66.97 Direct F7
holding TECH Stock Options (Right to Buy) 33,300 07 Dec 2022 Common Stock 33,300 $66.97 Direct F8
holding TECH Stock Options (Right to Buy) 43,988 07 Dec 2022 Common Stock 43,988 $93.11 Direct
holding TECH Restricted Stock Units 4,668 07 Dec 2022 Common Stock 4,668 Direct F4, F9
holding TECH Stock Options (Right to Buy) 18,240 07 Dec 2022 Common Stock 18,240 $120.46 Direct F9
holding TECH Stock Options (Right to Buy) 24,320 07 Dec 2022 Common Stock 24,320 $120.46 Direct F10
holding TECH Stock Options (Right to Buy) 24,664 07 Dec 2022 Common Stock 24,664 $94.52 Direct F11
holding TECH Restricted Stock Units 7,936 07 Dec 2022 Common Stock 7,936 Direct F4, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 82.0000 to 82.4900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Fully exercisable.
F3 Options to purchase13,292 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 13,288 shares vest on each of 8/7/2022 and 8/7/2023.
F4 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F5 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 9,992 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 9,988 shares vest on each of 8/5/2023 and 8/5/2024.
F7 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F8 Options to purchase 11,100 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
F9 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10 Options to purchase 6,080 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
F11 Options to purchase 6,168 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 6,164 shares vest on 8/15/2024 and 8/15/2026.
F12 2,644 shares vest on each of 8/15/2023 and 8/15/2025, and 2,648 shares vest on 8/15/2024.

Remarks:

On November 28, 2022, the Company completed a four-for-one stock split. All common stock amounts and exercise prices in the filing relating to securities acquired prior to November 28, 2022 have been adjusted to reflect the four-for-one stock split.